WHAT IS TRANSFER FACTOR?

1
WHAT IS TRANSFER FACTOR?

• THE MOST POWERFULL
• IMMUNE SYSTEM SUPPORT
• AVAILABLE TODAY
• and
• the safest too..

2
WHAT IS THE DIFFERENCE BETWEEN TF PLUS AND TF
ADVANCE FORMULA ?

• TF Plus and Advance Formula are different and
  must be applied differently depending on the
  condition of the patient.
• TF Plus is proven to be effective for numerous
  degenerative diseases and especially for growths
  in the body such as Cysts, Fibroids,
  Fibrodenomas, Cancers, etc.
• TF Advance Formula is applied to people with
  autoimmune diseases because it can balance and
  modulate the immune system

TF Plus boost NK cell activity 400 and TF
Advance Formula 283 above the normal immune
response
TF Advance Formula
TF Plus
3
LIST OF AUTOIMMUNE DISEASES
Neuromuscular system
Hepatobiliary system Autoimmune chronic active
hepatitis Primary biliary sclerosis Sclerosing
cholangitis Gastrointestinal tract
Gluten-sensitive enteropathy Pernicious anemia
Inflammatory bowel disease
Myasthenia gravis Emos-Lumbert myasthenic
syndrome Stiff man syndrome Acute disseminated
encephalomyelitis Multiple Sclerosis
Gullain-Barre syndrome Chronic inflammatory
demyelinating Polyradiculoneuropathy Multifocal
motor neuropathy with Conduction block Chronic
neuropathy with monoclonal Gammopathy
Paraneoplastic neurologic disorders Opsoclonus-my
oclonujs syndrome Cerebellar degneration
Encephalomyelitis Rectimopathy
4

• Skin
• Pemphigus vulgaris
• Pemphigus follaceus
• Paraneoplastic pemphigus
• Bullus pemphigoid
• Dermatitis herpetiformis
• Linear LgA disease
• Spidermolysis bullosa acquisita
• Autoimmune alopecia
• Erythera nodosa
• Pemphigoid gestaionis
• Cicatncial pemphigoid
• Chronic bullous disease of childhood
• Hematologic system
• Autoimmune hemolytic anemia
• Autoimmune thrombocytopenic purpura
• Idiopathic
• Drug related

• Endocrine System
• Thyroid Gland
• Hashimoto's thyroiditis
• Graves' Disease
• Thyroiditis with hyperthyroidism
• Type I autoimmune polyglandular syndrome
• Type II autoimmune polyglandular syndrome
• Insulin-dependent diabetes mellitus
• Immune-mediated infertility
• Autoimmune Addison's disease

5
Connective tissue diseases

• Allergic angitis granuloratosa
• (Chorg-Strauss Disease)
• Hypersensitivity vasolitis
• Wengener's granulomatosis
• Temporal arteritis
• Taksyasa's arteritis
• Kawasaki's disease
• Isolated vasculitis of the Central nervous system
  
• Thromboangitis obliterans
• Miscellaneous Vasculitides
• Sarcoidosis
• Graft-versus-host disease
• Cryopathies

• Systemic lupus erythematosus
• Rheumatoid arthritis
• Systemic sclerosis (scleroderma)
• Anklosing spondylitis
• Reactive ardrides
• Polymyositis/dermatomyositis
• Sjogren's syndrome
• Mixed connective tissue disease
• Bebcet's syndrome
• Psoriasis
• Vasculitic syndromes
• Systemic necrotizing vascolitides
• Classic polyarteritis nodosa

6
LIST OF TYPES OF CANCERS
Neuroendocrine Ovary Pancreas Penis Prostate
Skin Spinal cord Stomach Testes Thyroid
Unknown primary Vagina Vulva Womb (uterus)
Kaposi's sarcoma Kidney Larynx Leukaemia
Leukaemia, acute lymphoblastic Leukaemia, acute
myeloid Leukaemia, chronic lymphocytic
Leukaemia, chronic myeloid Liver Liver,
secondary Lung Lung, secondary Lymph nodes,
secondary Lymphoma, Hodgkin's Lymphoma,
non-Hodgkin's Melanoma Mesothelioma
Myeloma Soft tissue sarcomas

• Anal
• Bile duct
• Bladder
• Bone
• Bone, secondary
• Bowel (colon rectum)
• Brain
• Brain, secondary
• Breast
• Breast, secondary
• Carcinoid
• Cervix
• Children's cancers
• Endocrine
• Eye
• Gall bladder
• Gullet (oesophagus)
• Head neck

7

• BLADDER CANCER
• Bladder cancer affects twice as many men as women
  in the UK. It is the fourth most common cancer in
  men and the tenth most common in women. Each
  year, there are over 10,600 new cases.
• Bladder cancer is most common in people over 50.
  It affects the inner lining of the bladder and
  develops slowly. As it grows, it may spread to
  other organs near the bladder

• BONE CANCER
• Cancers that start in the bone are rare. There
  are around 500 new cases in the UK each year.
  They are different from cancers that develop at
  other sites in the body and spread to the bones
  later on.
• Bone cancer develops from cells in the bone. A
  rarer type can start in cartilage, the firm
  connective tissue that surrounds and cushions
  many joints. If the cancer is not treated, cancer
  cells from the original site may break away and
  spread to other parts of the body, such as the
  lungs, other bones, or other internal organs.

8

• BREAST CANCER
• Breast cancer is the most common cancer for women
  in this country. Each year, there are over 41,000
  new cases in the UK. This cancer accounts for
  almost one in three of all cancer cases in women,
  and the lifetime risk for breast cancer in women
  is one in nine.
• The cancer develops in the milk-producing glands
  in the breast, or in the passages or ducts that
  deliver milk to the nipples. Some breast cancers
  may spread into the surrounding tissue, and can
  spread to other parts of the body.

• BRAIN TUMORS
• Brain tumours are not very common, and unlike
  many other cancers, does not usually spread to
  other parts of the body. It accounts for less
  than 2 of all new cancers diagnosed in the UK.
• Each year, there are over 2,500 new cases of
  brain cancer in men, and over 1,900 cases in
  women. In the UK, about 300 children are
  diagnosed with a brain tumour each year.
• The brain is a soft spongy mass of nerve cells
  and supporting tissue. It controls every
  physiological system in the body and is
  responsible for our thoughts, language and
  emotions.
• In the brain, any abnormal growth puts pressure
  on sensitive structures and may impair their
  function.

9

• MULTIPLE MYELOMA
• Myeloma develops from cells within the bone
  marrow called plasma cells. Plasma cells produce
  proteins called antibodies, which help to fight
  infection. In myeloma, a single plasma cell
  develops faults and multiplies out of control.
  This makes the immune system much less effective
  at fighting infection.
• Myeloma cells produce excessive amounts of a
  single type of antibody, which is known as
  paraprotein, or monoclonal spike.
• Myeloma usually develops at a number of
  different sites within the body. This cancer is
  therefore called multiple myeloma. The most
  common sites for multiple myeloma are the pelvis,
  spine, rib cage, skull, shoulders and hips.

• CERVICAL CANCER
• Cervical cancer develops from cells lining the
  cervix, which is the canal that connects the
  uterus to the vagina. During childbirth, the baby
  passes through this canal.
• Cervical cancer takes time to develop. There is
  usually a period when some of the cells lining
  the cervix develop abnormal changes but are not
  yet cancerous - these can give rise to cervical
  cancer later on. Doctors can pick up these
  changes through screening, and a simple treatment
  can prevent cancer developing.

10

• HODGKINS LYMPHOMA
• Hodgkin's lymphoma is a fairly rare type of
  cancer, with just over 1,400 new cases in the UK
  every year. It is most common in people in their
  20s and 30s.
• This disease belongs to a group of cancers known
  as lymphomas. Lymphomas are cancers that develop
  from cells of the lymphatic system. This system
  helps to protect the body against infections.
• There are two main types of lymphoma, Hodgkin's
  lymphoma and non-Hodgkin's lymphoma.
• Hodgkin's lymphoma is named after Thomas
  Hodgkin, the doctor who first described it. It
  makes up less than one in five cases of lymphoma.
  The cancer cells in Hodgkin's lymphoma look
  different under a microscope from cells of
  non-Hodgkin's lymphoma.
• In the majority of cases, Hodgkin's lymphoma can
  be cured with modern treatments, particularly if
  the disease is in its early stages.
• If the cancer is not treated, cancer cells may
  break away and spread to other parts of the
  lymphatic system. If the cancer cells get into
  the blood stream, they can spread to almost any
  organ in the body, including the liver, lungs,
  brain and spine.

11

• MELANOMA
• There are two main types of skin cancer, melanoma
  and non-melanoma skin cancer. Melanoma is the
  most serious form of skin cancer.
• Melanoma (also known as malignant melanoma) is a
  cancer that develops from cells called
  melanocytes, which are found in the outer layer
  of our skin.
• Melanocytes produce melanin, a pigment that
  helps protect the deeper layers of our skin from
  the harmful effects of the sun. This pigment
  appears as a suntan, which is a sign of damaged
  skin.
• Melanomas often start in moles, but they can
  also develop elsewhere on the skin. In rare
  cases, melanomas can occur in the eye, under the
  fingernails, or in other parts of the body not
  usually exposed to the sun

• KARPOSIS SARCOMA
• Although Kaposi's sarcoma (KS) is a type of
  cancer it differs from other types of cancer in
  the way it develops. Unlike most cancers, which
  start in one place and may then spread around the
  body, KS can appear in several parts of the body
  at the same time. The most common site for KS is
  on the skin but it may also affect internal
  organs, particularly the lymph nodes, the lungs
  and parts of the digestive system.
• KS has been shown to be associated with a virus
  called Human Herpes Virus 8 (HHV8) and can affect
  people with a weakened immune system, including
  people with HIV (Human Immunodeficiency Virus)
  and AIDS.

12

• SOFT TISSUE SARCOMAS
• Soft tissue sarcomas are rare, and only 1,300 or
  so people a year in the UK will develop a
  sarcoma. Sarcomas are cancers that develop from
  cells in the soft, supporting tissues of the
  body. They can occur in muscle, fat, blood
  vessels or in any of the other tissues that
  support, surround and protect the organs of the
  body. The soft tissues of the body are also known
  as the mesenchyma, and so sometimes sarcomas are
  called mesenchymal tumours. Some types of sarcoma
  occur in children, teenagers and young adults,
  but generally sarcomas are more likely to develop
  in people over the age of 30.
• Some sarcomas, such as osteosarcoma, start in
  bone. These grow and develop differently and are
  treated differently from soft tissue sarcomas.

13

• Neuroendocrine tumours
• Neuroendocrine tumours are rare. They start in
  neuroendocrine cells - these are specialised
  nerve cells that produce hormones. Neuroendocrine
  cells are part of the endocrine system, which is
  a network of glands in the body. The glands
  produce hormones.
• Hormones control many of the bodys functions by
  controlling the levels of particular chemicals
  and fluids in the body, and they help us respond
  to changes in our environment.
• Neuroendocrine tumours occur most commonly in
  the digestive system but can occur in other parts
  of the body. They can be non-cancerous (benign)
  or cancerous (malignant).
• Some neuroendocrine tumours produce hormones
  which can cause particular symptoms, such as
  diarrhoea, flushing of the skin and wheezing.
  Tumours that produce hormones are called
  functioning (hormone-secreting). Tumours that
  don't produce hormones are known as
  non-functioning (non-hormone secreting).

14

• Mesothelioma
• Mesothelioma (pronounced mee-so-thee-lee-oma) is
  a cancer of the mesothelium. The mesothelium is a
  thin membrane that lines the chest and abdomen
  and surrounds the organs in these areas. The
  lining around the lungs is called the pleura and
  in the abdomen it is known as the peritoneum.
• Mesotheliomas are uncommon cancers, although
  they are becoming more frequent. Currently, about
  1800 people in the UK are diagnosed with
  mesothelioma each year.
• Mesothelioma of the lining of the lungs (pleural
  mesothelioma) is much more common than
  mesothelioma in the peritoneum. For every person
  with peritoneal mesothelioma there will be about
  12 people who have pleural mesothelioma.

15

• Cancers of the bile duct
• Cancers of the bile duct are rare in the Western
  world. There are approximately 600 new
  cholangiocarcinomas diagnosed each year in the
  UK.
• The bile ducts are the tubes connecting the
  liver and gall bladder to the small intestine
  (small bowel). Bile is a fluid made by the liver
  and stored in the gall bladder. Its main function
  is to break down fats during their digestion in
  the small intestine. In people who have had their
  gall bladder removed, bile flows directly into
  the small intestine. The bile ducts and gall
  bladder are known as the biliary system.
• Cancer is classified according to the type of
  cell from which it starts. Cancer of the biliary
  system almost always starts in a type of tissue
  called glandular tissue and is then known as
  adenocarcinoma.
• If the cancer starts in the part of the bile
  ducts contained within the liver it is known as
  intra-hepatic. If it starts in the area of the
  bile ducts outside the liver it is known as
  extra-hepatic.

16
Nose Cancer (Nasopharyngeal Cancer)

• The nasopharynx is the area where the back of the
  nose turns to meet the upper section of the
  throat. The cancerous tumour usually originates
  at the curved part behind the nose or the post
  nasal space. As the tumour is situated close to
  critical structures of the brain, spinal cord and
  throat, nasopharyngeal cancer can cause many
  symptoms in its advanced stages.

17

• It is common among the Chinese population,
  particularly in Hong Kong and Southern China. In
  Malaysia, we are talking about an incidence of 25
  cases for every 100,000 people in the population.
  According to the recent National Cancer
  Registry, nasopharyngeal cancer is the second
  most common cancer in Malaysian men, after lung
  cancer. In comparison to the rest of the world,
  the Malaysian Chinese male has the second highest
  incidence the local Chinese women have the
  highest incidence in the world. The incidence
  rises with age, particularly between the ages of
  50 and 60. But as our population expands, we are
  definitely seeing more cases in recent years.
  An epidemiology study in Hong Kong many years
  ago found an association between eating salted
  fish at a young age and the occurrence of nasal
  cancer. However, recent studies have implicated
  viral origin of the disease. He virus implicated
  is known as the Epstein-Barr virus. While many of
  us have that virus sitting dormantly behind our
  noses, some of us will eventually develop cancer
  due to the complex interaction of the virus and
  our genes. Other environmental factors include
  the consumption of preserved food and fermented
  fish products, as well as exposure to toxic fumes
  and tobacco.

18

• Symptoms
• Early symptoms include
• bleeding nose
• hearing problems, such as ringing and tingling
  
• blocked nose
• As the disease progresses, symptoms may include
• hearing loss
• numbness in the face
• coughing out blood
• swallowing problems
• breathing difficulties caused by a blocked
  nose
• double vision

19

• DiagnosisThe first stage of diagnosis involves
  a full ENT (ear, nose and throat) examination by
  a specialist, which includes examining the back
  part of the nose. If a swelling or bulge is
  present, a biopsy is indicated. A biopsy involves
  removing a small piece of tissue sample to
  determine the presence of cancer cell. It is
  essential in making a diagnosis. The ENT
  specialist is usually the first port of call for
  patients, as most of them think of their symptoms
  as common ENT problems. As soon as the ENT
  specialist detects something amiss or the biopsy
  is confirmed for cancer, the patient will be
  referred to an oncologist. The role of the
  clinical oncologist is to treat the cancer with
  radiotherapy or chemotherapy, or both. More
  tests will be done to determine the extent of
  disease and the best way to treat the patient.
  This includes a computed tomography (CT) scan or
  magnetic resonance imaging (MRI) of the head and
  neck area. X-ray or scans of the chest, liver and
  bone are also necessary to find out if the cancer
  has spread to those areas.

20

• TreatmentAt Stage I or II of the disease,
  where the tumour is confined to the back of the
  nose, the treatment choice is radiotherapy.
  Radiotherapy is an X-ray treatment using
  high-energy radiation to kill cancer cells.
  Radiation is given to the tumour site, which will
  also include the neck and throat. It is given
  daily from Mondays to Fridays for 7 weeks. At
  these early stages, treatment can achieve a cure
  rate of over 90 and recurrence is very unlikely
  if an experienced oncologist administers it. At
  Stages III and IV, when the lymph nodes have
  become infected with tumour (but the tumour has
  not progressed to other parts of the body),
  treatment is a combination of radiotherapy and
  chemotherapy. When both treatments are done
  concurrently, a cure of between 60 to 70 can be
  achieved compared to radiotherapy alone. The side
  effects are greater with combination treatment,
  but this is offset by higher cure rates.

21

• Side Effects Short-term complications start
  with dry mouth and loss of taste. This could lead
  to loss of appetite. By the 3rd and 4th week of
  treatment, there will also be difficulty in
  swallowing, which will persist throughout
  treatment. There may be some skin changes in the
  treated area. Fortunately, these side effects are
  only temporary and will last until treatment is
  completed. The taste capacity takes about 2
  months to recover, while the dry mouth never
  fully recovers, but its a small price to pay for
  cure. However, newer treatment techniques using
  CT scan-based treatment planning may help reduce
  these long-term side effects.
• By Dr Ibrahim Wahid

22

• LEUKEMIA
• Leukemia is cancer of the white blood cells. The
  bone marrow produces abnormal white blood cells
  that do not function properly and eventually
  crowd out normal white blood cells, red blood
  cells (erythrocytes), and platelets. There are
  four major types of leukemia, depending on the
  type of white blood cell affected and the speed
  of progression. Blood cells in the bone marrow
  form from two major groups of stem cells the
  myeloid stem cell line and the lymphoid stem cell
  line. Myeloid stem cells develop into red blood
  cells, platelets, and certain kinds of white
  blood cells (granulocytes or monocytes). The
  lymphoid stem cell line develops into a kind of
  white blood cell called lymphocytes. Both stem
  cell lines can be affected by leukemia, and both
  occur in both acute and chronic forms. Acute
  leukemia progresses rapidly chronic more slowly.

23

• The four types are
• Acute lymphoblastic leukemia (ALL) is the most
  common form of leukemia in children, but it can
  also affect adults.
• Acute myelogenous leukemia (AML) is the most
  common form of leukemia and can affect both
  children and adults.
• Chronic lymphocytic leukemia (CLL) primarily
  affects people older than 55 years of age, and
  rarely affects children.
• Chronic myelogenous leukemia (CML) affects
  primarily adults. Unlike CLL, CML eventually but
  invariably converts to the more rapidly
  progressing acute form if untreated.

24

• Causes of Leukemia The exact cause of most
  types of leukemia is unknown. Many patients do
  not exhibit any of the known risk factors, which
  include smoking and other tobacco use, exposure
  to high doses of radiation or the chemicals
  benzene or formaldehyde, and chemotherapy used to
  treat other cancers. Leukemia is not an inherited
  disease, but there may be a genetic link.
  Depending on the type of leukemia, close
  relatives of a person with leukemia may be up to
  four times as likely to develop leukemia as a
  person with no affected relatives. Down syndrome
  and certain types of blood disorders also
  increase the risk of developing the disease.

25

• Symptoms and Diagnosis of Leukemia As affected
  cells increase, they begin to crowd out normal
  cells and disable them, causing symptoms such as
  frequent infections, poor healing of small cuts
  or sores, and anemia. The leukemia cells may also
  collect in certain parts of the body, causing
  pain and swelling. Other common symptoms include
  fevers and night sweats, weakness and fatigue,
  headaches, bruising of the skin and bleeding from
  the gums or rectum, joint pain, swelling in the
  abdomen from an enlarged spleen, swollen lymph
  nodes in the armpit, neck, or groin, and
  decreased appetite or weight loss. If you or a
  relative has leukemia symptoms, a personal and
  family medical history will be taken, and a blood
  sample sent to the lab for testing. If your blood
  tests are abnormal, a test of bone marrow cells
  will be taken to confirm the diagnosis. A spinal
  tap (lumbar puncture) may also be ordered to
  determine whether leukemia cells are present in
  the brain or cerebrospinal fluid.

26

• Treatment of Leukemia Treatment depends on the
  type of leukemia and the stage of progression,
  but commonly includes one or more bone marrow
  transplants, radiation, and chemotherapy. Our
  understanding and ability to treat leukemia has
  come a long way in recent decades. In 1960, the
  5-year survival rate for all types of leukemia
  was about 14. Now it is about 50. The highest
  survival rates occur in children suffering from
  ALL.

27

• Methods of Treatment
• Most patients with leukemia are treated with
  chemotherapy. Some also may have radiation
  therapy and/or bone marrow transplantation (BMT)
  or biological therapy. In some cases, surgery to
  remove the spleen (an operation called a
  splenectomy) may be part of the treatment plan.
• - Chemotherapy is the use of drugs to kill cancer
  cells. Depending on the type of leukemia,
  patients may receive a single drug or a
  combination of two or more drugs. Some anticancer
  drugs can be taken by mouth. Most are given by
  intravenous injection (injected into a vein).
  Often, patients who need to have many IV
  treatments receive the drugs through a catheter.
• - One end of this thin, flexible tube is placed
  in a large vein, often in the upper chest. Drugs
  are injected into the catheter, rather than
  directly into a vein, to avoid the discomfort of
  repeated injections and injury to the skin.
• - Anticancer drugs given by IV injection or taken
  by mouth enter the bloodstream and affect
  leukemia cells in most parts of the body.
  However, the drugs often do not reach cells in
  the central nervous system because they are
  stopped by the blood-brain barrier. This
  protective barrier is formed by a network of
  blood vessels that filter blood going to the
  brain and spinal cord. To reach leukemia cells in
  the central nervous system, doctors use
  intrathecal chemotherapy. In this type of
  treatment, anticancer drugs are injected directly
  into the cerebrospinal fluid.

28

• Intrathecal chemotherapy can be given in two
  ways. Some patients receive the drugs by
  injection into the lower part of the spinal
  column. Others, especially children, receive
  intrathecal chemotherapy through a special type
  of catheter called an Ommaya reservoir. This
  device is placed under the scalp, where it
  provides a pathway to the cerebrospinal fluid.
  Injecting anticancer drugs into the reservoir
  instead of into the spinal column can make
  intrathecal chemotherapy easier and more
  comfortable for the patient.
• Chemotherapy is given in cycles a treatment
  period followed by a recovery period, then
  another treatment period, and so on. In some
  cases, the patient has chemotherapy as an
  outpatient at the hospital, at the doctor's
  office, or at home. However, depending on which
  drugs are given and the patient's general health,
  a hospital stay may be necessary.

29

• Radiation therapy is used along with chemotherapy
  for some kinds of leukemia. Radiation therapy
  (also called Radiotherapy) uses high-energy rays
  to damage cancer cells and stop them from
  growing. The radiation comes from a large
  machine.
• Radiation therapy for leukemia may be given in
  two ways. For some patients, the doctor may
  direct the radiation to one specific area of the
  body where there is a collection of leukemia
  cells, such as the spleen or testicles. Other
  patients may receive radiation that is directed
  to the whole body. This type of radiation
  therapy, called total-body irradiation, usually
  is given before a bone marrow transplant.

30

• The term leukemia refers to cancers of the white
  blood cells, which are also referred to as
  leukocytes or WBCs. When a child has leukemia,
  large numbers of abnormal white blood cells are
  produced in the bone marrow. These abnormal white
  cells crowd the bone marrow and flood the
  bloodstream, but they cannot perform their proper
  role of protecting the body against disease
  because they are defective.
• As leukemia progresses, the cancer interferes
  with the body's production of other types of
  blood cells, including red blood cells and
  platelets. This results in anemia (low numbers of
  red cells) and bleeding problems, in addition to
  the increased risk of infection caused by white
  cell abnormalities.
• As a group, leukemias account for about 25 of
  all childhood cancers and affect about 2,200
  American young people each year. Luckily, the
  chances for a cure are very good with leukemia.
  With treatment, most children with leukemia are
  free of the disease without it coming back.

31

• Types of Childhood Leukemia
• In general, leukemias are classified into acute
  (rapidly developing) and chronic (slowly
  developing) forms. In children, about 98 of
  leukemias are acute.
• Acute childhood leukemias are also divided into
  acute lymphocytic leukemia (ALL) and acute
  myelogenous leukemia (AML), depending on whether
  specific white blood cells called lymphyocytes,
  which are linked to immune defenses, are
  involved.
• Approximately 60 of children with leukemia have
  ALL, and about 38 have AML. Although
  slow-growing chronic myelogenous leukemia (CML)
  may also be seen in children, it is very rare,
  accounting for fewer than 50 cases of childhood
  leukemia each year in the United States.

32

• Risk for Childhood Leukemia
• The ALL form of the disease most commonly occurs
  in younger children ages 2 to 8, with a peak
  incidence at age 4. But it can affect all age
  groups.
• - Children have a 20 to 25 chance of developing
  ALL or AML if they have an identical twin who was
  diagnosed with the illness before age 6. In
  general, nonidentical twins and other siblings of
  children with leukemia have two to four times the
  average risk of developing this illness.
• - Children who have inherited certain genetic
  problems - such as Li-Fraumeni syndrome, Down
  syndrome, Kleinfelter syndrome,
  neurofibromatosis, ataxia telangectasia, or
  Fanconi's anemia - have a higher risk of
  developing leukemia, as do children who are
  receiving medical drugs to suppress their immune
  systems after organ transplants.
• - Children who have received prior radiation or
  chemotherapy for other types of cancer also have
  a higher risk for leukemia, usually within the
  first 8 years after treatment.

33

• In most cases, neither parents nor children have
  control over the factors that trigger leukemia,
  although current studies are investigating the
  possibility that some environmental factors may
  predispose a child to develop the disease. Most
  leukemias arise from noninherited mutations
  (changes) in the genes of growing blood cells.
  Because these errors occur randomly and
  unpredictably, there is currently no effective
  way to prevent most types of leukemia.
• To limit the risk of prenatal radiation exposure
  as a trigger for leukemia (especially ALL), women
  who are pregnant or who suspect that they might
  be pregnant should always inform their doctors
  before undergoing tests or medical procedures
  that involve radiation (such as X-rays).
• Regular checkups can spot early symptoms of
  leukemia in the relatively rare cases where this
  cancer is linked to an inherited genetic problem,
  to prior cancer treatment, or to use of
  immunosuppressive drugs for organ transplants.

34
WHAT ARE THE ALTERNATIVES TO TRANSFER FACTOR AND
IMMUNOTHERAPY

• Cancer Treatments
• 1) Active surveillance (or watchful waiting) -
  Some types of cancer grow very slowly and may
  cause no problems for many years.
• 2) Surgery - An operation is done to remove the
  tumour
• 3) Radiotherapy - use of high energy x-rays to
  destroy
• cancer cells
• 4) Chemotherapy - use of anti-cancer (cytotoxic)
  drugs to destroy cancer cells.
• 5) Hormonal Therapy - work by altering the levels
  of particular hormones in the body.
• 6) Other treatments - biological therapies and
  include interferon and interleukin.

35
CANCER RESEARCH - CHEMOTHERAPY AND REAL
THERAPIES

• The medical establishment works closely with the
  drug multinationals whose main objective is
  profits, and whose worst nightmare would be an
  epidemic of good health. Lots of drugs MUST be
  sold. In order to achieve this, anything goes
  lies, fraud, and kickbacks. Doctors are the
  principal salespeople of the drug companies. They
  are rewarded with research grants, gifts, and
  lavish perks. The principal buyers are the public
  - from infants to the elderly - who MUST be
  thoroughly medicated and vaccinated...at any
  cost!
• Why do the authorities forbid alternative
  medicine? Because they are serving the industry,
  and the industry cannot make money with herbs,
  vitamins, and homeopathy. They cannot patent
  natural remedies. That is why they push
  synthetics. They control medicine, and that is
  why they are able to tell medical schools what
  they can and cannot teach." Guylaine Lanctot, M.D
  

36
Chemotherapy Afraid of Their Own Medicine

• In one survey, most oncologists specializing in
  lung cancer reported that they would not take
  chemotherapy if they had the disease. Yet,
  everyday these doctors give their patients
  chemotherapy.
• In conversation with an investigative reporter,
  one brain cancer specialist admitted that he
  would never submit to radiation if he had a brain
  tumor. Nevertheless, he continues to send
  patients for radiation, because he would be
  kicked out of the hospital if he didn't follow
  the accepted protocol.
• Based on information in Townsend Letter for
  Doctors and Patients, Jan 1998 Spectrum,
  Mar/April 1998

37
"Drugs do not cure, popular opinion
notwithstanding. Cure must come from within or
there is no cure"
- M.L. Tyler M.D
38
DANGERS OF CHEMOTHERAPY

• William Campbell Douglass II, MD - "To understand
  the utter hypocrisy of chemotherapy, consider the
  following The McGill Cancer Center in Canada,
  one of the largest and most prestigious cancer
  treatment centers in the world, did a study of
  oncologists to determine how they would respond
  to a diagnosis of cancer.
• On the confidential questionnaire, 58 out of 64
  doctors said that all chemotherapy programs were
  unacceptable to them and their family members.
  The overriding reason for this decision was that
  the drugs are ineffective and have an
  unacceptable degree of toxicity. These are the
  same doctors who will tell you that their
  chemotherapy treatments will shrink your tumor
  and prolong your life!

39
THE POLITICS OF CANCER REVISTED

• "The National Cancer Institute and the American
  Cancer Society have misled and confused the
  public and Congress by repeated false claims that
  we are winning the war against cancer -- claims
  made to create public and Congressional support
  for massive increases in budgetary
  appropriations." Dr. Epstein 

40
Gangsters In Medicine

• The Journal of the American Medical Association
  recently reported that as many as 106,000 deaths
  occur annually in US hospitals due to adverse
  reactions to prescription drugs that are properly
  prescribed by physicians that use them as
  directed by the drug companies.
• The National Council for Patient Information and
  Education reported that an additional 125,000
  deaths occur annually due to adverse reactions to
  drugs that the physician never should have
  prescribed.
• The annual death toll from synthetic prescription
  drugs, both from the correctly prescribed and the
  incorrectly prescribed, amounts to about 231,000
  deaths every year.
• From the article Gangsters in Medicine by
  Thomas Smith

41
Classes of Drugs

• Chemotherapy drugs for non-metastatic and
  metastatic breast cancer fall into several
  categories
• 1) Alkylators - affect cancer cells much like
  radiation does by damaging the proteins that
  control growth in the genes of the tumor cell.
• 2) Antimetabolites - act as false building
  blocks in a cancer cell's genes, causing it to
  die as it gets ready to divide.

42

• 3) Antibiotics - (not to be confused with
  antibiotics that fight infection) include potent
  inhibitors of gene replication. ("Anti" means
  "against," and "biotic" means "growth.")
• 4) Antimiotic agents - or natural agents rob
  cellular genes of the ability to reproduce
  themselves during division.
• 5) Antimicrotubule - or natural agents interfere
  with cell structure and cell division.

43
CHEMOTHERAPY DRUGS

• Leustat
• Matrex
• Mitoxana
• Myleran
• Myocet
• Navelbine
• Nipent
• Oncovin
• Pharmorubicin
• Puri-Nethol
• Sodiofolin
• Taxol
• Taxotere
• Temodal
• Tomudex
• Uftoral
• Uromitexan
• Velbe
• Vepesid

• 2'DCF
• 2'-deoxycoformycin
• 5FU
• Alkeran
• BiCNU
• Caelyx
• Campto
• Cosmegen Lyovac
• DTIC
• Eldisine
• Eloxatin
• Etopophos
• Erwinase
• Fludara
• Gemzar
• Hexalen
• Hycamtin
• Hydrea
• Isovorin

44
COMMON FAVOURED DRUGS FOR CHEMO Idarubicin

• Idarubicin is chemotherapy that is given as a
  treatment for some types of cancer. It is most
  commonly used to treat breast cancer, and some
  types of leukaemia.
• Possible side effects
• Each persons reaction to chemotherapy is
  unique. Some people have very few side effects,
  while others may experience more. The side
  effects described in this information will not
  affect everyone who is given idarubicin, and may
  be different if you are having more than one
  chemotherapy drug. (continue to next slide.)

45

• Lowered resistance to infection
• 2) Bruising or bleeding
•  
• 3) Anaemia (low number of red blood cells)
• 4) Nausea (sickness) and vomiting
• 5) Sore mouth and taste change
• 6) Tiredness and a general feeling of weakness
• 7) Hair loss
• 8) Discoloured urine
• -- and several others less common side effects

46
WHO GETS CANCER ?

• 1 in 3 people will develop cancer during their
  lifetime, but cancer is not common in children or
  young people - it mainly occurs in the later
  years of life.
• Cancers can occur at any age, but the risk of
  developing cancer increases with age. Over 70 of
  all newly diagnosed cancers occur in people aged
  60 years or more.

47
WHY DO CANCERS KEEP COMING BACK ?

• A cancerous (malignant) tumour consists of cancer
  cells which have the ability to spread beyond the
  original site. If left untreated they may invade
  and destroy surrounding tissues.
• Sometimes cells break away from the original
  (primary) cancer and spread to other organs in
  the body by travelling in the bloodstream or
  lymphatic system. When these cells reach a new
  area of the body they may go on dividing and form
  a new tumour, often referred to as a "secondary"
  or a "metastasis".

48
TRANSFER FACTOR STUDY ON 20 CANCER PATIENTS

• Rob Robertson, M.D. conducted the following
  studies
• Twenty patients, 12 men and 8 women, were
  selected for this in vivo study.  The average age
  was 49.3.  The twenty individuals were each level
  3 or level 4 cancer patients.  Each patient was
  basically sent home by his or her oncologist to
  die.  The average life expectancy was 3.7
  months.  
• The protocol was to place each patient on 9
  capsules per day of Transfer Factor Plus.  The
  patients were given a number of other general
  nutrients.  After eight months, 16 of these
  individuals were still living and were either in
  remission, improving or stabilized.

49
Overcoming Immunosuppression from Chemotherapy

• Cancer patients who are undergoing chemotherapy
  or radiation which greatly weaken the immune
  system, can greatly benefit from taking transfer
  factor supplementation. Transfer factor
  supplementation serves to protect the body from
  "opportunistic" infections, which often occur
  during these treatments. 
• Dr Duane Townsend, former director of gynecologic
  oncology at LDS Hospital in Salt Lake City, puts
  all of his cancer patients on transfer factor
  treatments to boost their immune systems
  abilities to respond to any health challenges.

50
No Rights for a Child..(a true story by parents
Raphaele Michael Horwin)

• Over forty years ago, those powerful words were
  written and endorsed by many nations throughout
  the world including the United States. It is a
  beautiful declaration but sadly it is only an
  illusion. The medical establishment took every
  single one of those rights away from our only
  child Alexander. Without the right to live, there
  are no opportunities for affection, play, or
  love.
• Alexander was two years old when he was diagnosed
  with medulloblastoma, the most common pediatric
  brain tumor. This cancer is rising in frequency.
• After the first round of chemo, Alexander began
  to change. Even after two brain operations,
  Alexander was still a vibrant, ruddy, strong,
  energetic child. But as the chemotherapy
  repeatedly filled his small body Alexander began
  to die inside.

51
- First the relentless stomach pains and the
horrendous projectile vomiting began. Then his
beautiful curly hair fell out. Next his dark
skin tone turned pale as a ghost. He got sick
with fevers and spent weeks in the hospital. -
Then there were the blood transfusions to replace
the blood cells the chemo had killed, the hearing
tests to see if the chemo drug cisplatin had not
devastated too much of his hearing, the nuclear
medicine tests to check if his kidneys were not
giving up under the strain of processing so much
poison, the liver function tests to ensure that
his liver was not being destroyed, etc. - During
chemotherapy we had to squeeze an antibiotic into
his nose called nystatin several times a day. He
hated it and buried his face in a pillow when he
saw it coming with all the strength his little
body could muster. One of us had to pin
Alexander down and keep his head immobile while
the other pushed the syringe into each nostril
and injected the solution. We were also called
upon to give him GCSF injections at home.
52
- Then we found the following statement written
by Hyder in our sons medical chart. It was
dated September 26, 1998 Dr. Heideman also
called me because he was very concerned about Mr.
and Mrs. HorwinHe was very concerned that the
family would refuse treatment and that a court
order would have to be obtained to treat
Alexander. - And on October 6, 1998 Hyder
continued I think that if Mr. and Mrs. Horwin
do not bring Alexander in for chemotherapy
tomorrow, additional steps will be necessary.
- We went to see an attorney to find out if the
oncologists could take Alexander from us if we
decided to stop chemo. Incredibly, the answer
was yes !.
53
- The oncologists warned us that if we didnt use
chemotherapy that the tumor would probably return
in three months. These doctors assured us that
the chemo they were administering to our son was
the current state-of-the-art. They told us
repeatedly that this was Alexanders best choice
for a long and healthy life. - We continued the
chemotherapy. As a result of the drugs,
Alexanders balance was lost, his ability to see
deteriorated, and he lost hearing in one ear.
The whole thing was horrendous. - After a
clean MRI on January 4th, Alexander had a
spinal tap. A day later Alexander complained of
pain in his head and back and he began to vomit.
We asked for another MRI but Hyder, the
oncolgist, refused because he had done one just a
few days previously. Hyder told us that
Alexanders pain was just a side effect of the
spinal tap. But as each day passed the pain
became worse.
54
- We brought Alexander into the hospital on
January 11th and Hyder ordered a CAT scan without
contrast. We were told that the scan looked
fine, although later, we would find out that a
CAT scan especially one taken without contrast is
not designed to reveal the presence of a
returning brain tumor. - Finally, on January
18th, we brought Alexander into the hospital and
demanded a MRI. Hyder refused to order the test.
He explained that it was too late in the day to
schedule one. We had a confrontation. We would
not leave until a MRI was ordered. Finally,
Hyder relented. Alexander was wheeled into the
MRI suite. - An hour later we had the news,
Hyder shook his head and told us that Alexander
had over 30 tumors throughout his brain and
spine. What does that mean? we asked
completely stunned. Hyder just continued to shake
his head.
55
What is it? we asked him. Leptomeningeal
sarcoma. I am so sorry. There is nothing we can
do. How is this possible? It happens, he
said. How often, we asked. It happens
sometimes. Im so sorry. How long does
Alexander have, we asked. The surgeon paused.
A few days, perhaps, he said. The only thing
we can do is send you home with hospice care.
Ill give you a prescription for morphine and
decadron, Hyder said as he awkwardly patted me
on the shoulder. I think it is better to keep
your son here tonight and you can go home
tomorrow, he added. Alexander died on January
31st, 1999 in his mommys arms. Our son was only
2 ½ years old. After Alexander was buried,
Raphaele and I wanted to know what happened. No
one ever told us that the cancer could come back
and kill Alexander while he was on chemotherapy.
In fact, Alexander was only one quarter through a
twelve-month chemo protocol (comprised of
induction and maintenance chemotherapy).
56
The following quotes are taken verbatim from
Alexanders medical chart. Each entry is written
by Hyder.

• September 25, 1998
• Mr. and Mrs. Horwin and I discussed treatment
  options in the office for about two hoursWe
  discussed the risks of chemotherapy at length
  including low hemoglobin, low white blood cells,
  low platelets, infection, need for blood
  transfusion, need for platelet transfusion, pain,
  nausea, vomiting, hair loss, skin injury, heart
  damage, lung damage, liver damage, kidney damage,
  loss of hearing, small stature, hormonal problems
  such as low growth hormone or low thyroid
  hormone, infertility, second cancer, intellectual
  decline, worsening of neurological symptoms,
  ineffectiveness, and death. Mr. and Mrs. Horwin
  were quite distressed by all the potential side
  effects, but I explained that despite all these
  risks, I believe the potential benefits of
  chemotherapy in prolonging the length of cancer
  free survival or possibly cure are greater than
  the potential risks.
• (-- continue to next slide)

57

• October 2, 1998
• without chemotherapy I am quite certain that the
  disease will relapse and this could possibly
  result in Alexanders death. PLANS We will
  proceed with chemotherapy like CCG-9921A, as the
  best available therapy.
• October 3, 1998
• I received your voice mail message that you have
  decided not to bring Alexander for scheduled
  chemotherapy todayAlexander needs chemotherapy
  nowWe need to get chemotherapy started if
  Alexander is to survive this disease.
• (-- continue to next slide)

58

• October 6, 1998
• About 430 p.m. on October 5, 1998, Mr. Horwin
  telephoned and asked me about a variety of
  biological therapies such as nerve cell growth
  factor, retinoic acid, and tumor necrosis
  factorMr. Horwin asked to use these biological
  therapies for his son before chemotherapy. I
  again told him clearly in my professional
  opinion, chemotherapy is the next treatment to
  use because of its known clinical efficacy. He
  was distressed by the limitations of
  chemotherapy, since treatment is successful in
  only about 30-40 of children with Alexanders
  type of cancerI explained that the best
  opportunity we have to successfully treat
  Alexanders cancer is to use chemotherapy nowI
  reiterated that my best professional advice which
  is to use chemotherapy now against Alexanders
  cancer. I spoke to Mrs. Horwin and explained
  what I had explained to her husband. I told her
  that my best medical advice is to use
  chemotherapy for treatment of Alexanders cancer.
  I told her that without chemotherapy, Alexander
  may die from cancer

59
- We began to research leptomeningeal sarcoma
the cancer that had grown so rapidly and killed
him. One of the abstracts that came back stunned
us. - It was a study published in 1994 by Dr.
Heideman, the oncologist we had met at St. Judes
Childrens Research Hospital. It discussed the
leptomeningeal progression of medulloblastoma
in thirteen children Alexanders age who were
given chemotherapy. It explained how the cancers
returned and spread in eleven of the thirteen
children within five months. - It mentioned
that for some of the children the cancers grew in
the spines. Incredibly, this abstract described
in detail exactly what happened to our son. But
even more astounding, the abstract explained that
this protocol was terminated due to the poor
performance of the drugs. - The chemo that they
had given these children was identical to the
chemo Hyder had administered to Alexander. The
four drugs were exactly the same - vincristine,
cisplatin, cyclophosphamide and etoposide. The
cancer that returned, metastasized and took
Alexanders life did so in less than five months
from the time when he had his surgeries
60
- What you are about to read will shock you. It
is a story of oncologists lying to parents and
the public about the efficacy of their therapy.
The quotations that follow come from abstracts
and articles printed in their peer reviewed
medical journals that trace the use of these
drugs in children starting almost a quarter of a
century ago. It is organized in chronological
order. Incredibly, all these drugs are still
being administered to children in hospitals
throughout the country, sometimes without the
parents consent. Alexander was put on
protocol CCG 9921 that consists of -
Vincristine - Cyclophosphamide -
Cisplatin (very similar to Carboplatin) -
Etoposide (also called VP 16) - 1976
- Vincristine causes seizures In 1976, the
oncologists experiment on children with a drug
called vincristine. Twenty-two years later, they
would administer the same drug to Alexander.
Here in 1976 they find that the drug causes
seizures.
61
-1978- Vincristine does not eliminate cancer A
year later, they tested vincristine with two
other chemotherapy drugs on more children. The
tumors returned in an average of 45 weeks with
the chemo. -1982- Vincristine destroys eyesight
The fact that oncologists were already warned
that vincristine was dangerous to a childs
eyesight didnt seem to make an impression. It
didnt for Alexanders oncologist in 1998. This
article is written about another child who nearly
goes blind from vincristine in 1982. -1983- Cispl
atin destroys hearing and leads to neurologic
deterioration In 1983, the danger of another
chemo drug, cisplatin, is discovered, but only
after trying it out on children. This is another
drug the oncologists would inject into Alexander
fifteen years later.
62
- Six children received cisplatin for recurrent
brain tumor. Five of the six children had
evidence of significant hearing loss after only
one cycle of treatment. Two (children)developed
profound deterioration in neurologic status
within 72 hours after infusion. - Granowetter
L, Rosenstock JG, Packer RJ Enhanced
cis-platinum neurotoxity in pediatric patients
with brain tumors. J Neurooncol 1983 1(4)293-7.
- Cyclophosphamide does not affect survival
That same year, another chemotherapy drug called
cyclophosphamide is tried out on children. It
does not effect survival. This is the third of
four drugs they would administer to Alexander
many years later. This article admits that even
if a drug is active and temporarily shrinks a
tumor, it does not prolong life. - A case of
fatal myeloencephalopathy (inflammation of the
spinal chord and brain) secondary to accidental
intrathecal administration of vincristine is
reported in a 16 year old boy. He underwent a
progressive ascending chemical meningoencephalitis
leading to coma, and died 36 days after the
injection. At autopsy, all regions of the brain
that had been in direct contact with the
cerebrospinal fluid were necrotic (dead).
63
Gonadal function was studied in two groups of
children previously treated for
medulloblastomaIn group one, but not in group
two, the children also received adjuvant
chemotherapy (BCNU or CCNU plus vincristine in
four and procarbazine in three patients). The
nine children in group one showed clinical and
biochemical evidence of gonadal damage In group
two, each child(developed) normallyWe conclude
that nitrosoureas (chemotherapy) was responsible
for the gonadal damage - Ahmed SR, Shalet SM,
Campbell RH, Deakin DP. Primary gonadal damage
following treatment of brain tumors in childhood.
J Pediatr 1983 Oct 103(4) 562-5. -1984-
Oncologists may not count dead children in their
statistics The next year, several chemo drugs
including vincristine, and etoposide, are
administered to children in another chemo
experiment. Etoposide is the fourth and last
drug in the chemo cocktail they would administer
to Alexander fourteen years later.
64
-1985- Oncologists admit that chemo is
ineffective A year later, after trying out all
the various chemo drugs on children, a group of
pediatric oncologists admit that the role of
chemotherapy is unclear, that responses are
generally transient, and virtually no cures are
reported. They also admit again that an
active drug (a drug that may temporarily shrink
a tumor) has no relationship to a cure. -1987-
Oncologists admit that chemo is ineffective and
increases the risk of infection The (survival)
rate was not improved by the chemotherapy
program. An increased risk of infection was
associated with the chemotherapy. - Jenkin RD,
Boesel C, Ertel I, Evans A, Hittle R, Ortega J,
Sposto R, Wara W, Wilson C, Anderson J, et al.
Brain-stem tumors in childhood a prospective
randomized trial of irradiation with and without
adjuvant CCNU, VCR, and prednisone. A report of
the Childrens Cancer Study Group. J Neurosurg
1987 Feb 66(2) 227-33.
65
The fact that chemotherapy actually causes cancer
should be of no surprise to the oncologists. The
chemotherapy they gave Alexander and thousands of
other children is listed as Known Human
Carcinogens by the National Institute of Health,
the National Cancer Institute and the FDA. In
fact, cyclophosphamide was listed as a Known
Human Carcinogen by the First Annual Report on
Carcinogens published by the U.S. Department of
Health and Human Services in 1980. In addition,
there are four other chemotherapy compounds on
that list. Furthermore, the World Health
Organizations International Agency for Research
on Cancer lists ten chemotherapy agents including
cyclophosphamide and all alkylating agents as
Materials known to be carcinogenic to humans.
66

• It is hard to believe that oncologists would be
  injecting known human carcinogens into children
  with cancer. But, that is exactly what they are
  doing. They should not feign surprise when the
  children begin developing secondary cancers.
• This is what happened to Alexander. His first
  cancer was medulloblastoma. After three months
  of chemotherapy the cancer returned as 30
  separate tumors. At that point the doctors
  called it leptomeningeal sarcoma.
• -1991-
• Chemo leads to destruction of hearing,
  infertility and secondary cancers.
• - Complications of chemotherapy
  include,permanent hearing impairment secondary
  to cisplatin, infertility and an increased risk
  of second primary neoplasms.
• - Allen JC Complications of chemotherapy in
  patients with brain and spinal cord tumors.
  Pediatr Neurosurg 1991-92 17(4) 218-24

67
-1993- The chemo is not the problem, its the
children who are at fault Its 1993 and the
oncologists have a new strategy - blame the
victim. The drugs are exactly the same. Now,
the problem isnt that the chemotherapy is
worthless. The problem is the children. They
just have a poor prognosis. Children younger
than 5 years who have PNET have a poor
prognosis. - Goldwein JW, Radcliffe J, Packer
RJ, Sutton LN, Lange B, Rorke LB, DAngio GJ.
Results of a pilot study of low-dose craniospinal
radiation therapy plus chemotherapy for children
younger than 5 years with primitive
neuroectodermal tumors. Cancer 1993 Apr 15
71(8) 2647-52.
68
- Today, according to the oncologists, children
on chemotherapy have their brain cancers return
in an average of 5-7 months. With chemo,
Alexander lived a little more than five months
from when he was diagnosed and he had all his
tumor removed. - Incredibly, the children
operated on 70 and 80 years ago already beat
Alexander in terms of survival, but if these kids
had had the benefit of a modern surgery they
might have lived even longer. Who knows how long
these children would have lived if they had been
given a modern operation? - This suggested
that chemotherapy was shortening childrens
lives, not lengthening them!
69
-1998- But even after these admissions that
virtually no cures are reported with chemo in
1985, that chemo is controversial in 1991,
unproven in 1993, and provides a poor rate of
survival and high treatment associated morbidity
(i.e. side effects) in 1997, nothing changes.
Here we are in 1998. The children are still
getting the same drugs. The children die of the
disease or the chemo itself. The conclusion is
that the treatment doesnt work. How many dead
children did it take to reach that conclusion?
Whats worse is that even with that conclusion,
the oncologists continue to use these drugs on
children.
70
(No Transcript)